期刊文献+

血塞通注射液与扶正化瘀胶囊治疗肝纤维化的效果研究

Study on the effect of Xuesaitong injection with Fuzheng Huayu capsule in treatment of liver fibrosis
下载PDF
导出
摘要 目的分析血塞通注射液与扶正化瘀胶囊治疗肝纤维化的效果。方法以68例肝纤维化患者为研究对象,电脑随机平均分为研究组与对照组。对照组给予扶正化瘀胶囊治疗,研究组给予血塞通注射液联合扶正化瘀胶囊治疗,对比2组患者治疗效果。结果研究组治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05)。结论采用血塞通注射液与扶正化瘀胶囊联合治疗肝纤维化,疗效显著。 Objective To analyze the effect of Xuesaitong injection with Fuzheng Huayu Capsule in treating hepatic fibrosis.Methods 68 patients with hepatic fibrosis patients as the object,the computer randomly divided into study group and control group. The control group received Fuzheng Huayu capsule treatment,study group,Xuesaitong injection combined with Fuzheng Huayu capsule treatment,contrast the effect of treatment in patients with treatment of patients. Results The total efficiency comparison,the study group was significantly higher than the control group,the difference was statistically significant(P0.05).Conclusion The Xuesaitong injection with Fuzheng Huayu Capsules in the treatment of liver fibrosis,a significant effect.
出处 《基层医学论坛》 2017年第13期1601-1602,共2页 The Medical Forum
关键词 血塞通注射液 扶正化瘀胶囊 肝纤维化 临床疗效 Xuesaitong injection Fuzheng Huayu capsule Hepatic fibrosis Clinical effect
  • 相关文献

参考文献5

二级参考文献36

  • 1朱肖鸿,叶蕾.非创伤性指标评判安珐特治疗肝纤维化的疗效[J].临床肝胆病杂志,2005,21(5):301-302. 被引量:3
  • 2赵长青,吴艺青,徐列明.扶正化瘀胶囊抗肝纤维化的临床疗效和作用机制[J].中西医结合学报,2006,4(5):467-472. 被引量:63
  • 3Liver Disease Committee,Chinese Association of Integrative Medicine..肝纤维化中西医结合诊疗指南[J].中华肝脏病杂志,2006,14(11):866-870. 被引量:270
  • 4Moher D,Liberati A,Tetzlaff J,et al.Pm feed reporting items for systematic reviews and meta analyses:the PRISMA statement[J].Journal of Clinical Epidemniology,2009,62 (10):1006-1012.
  • 5Cummings K J,Lee SM,West ES,et al.Interferon and ribavirin vs interferon alone inthe retreatment of chronic hepatitis C previously nonresponsive to interferon:A meta-analvsi-s of randomized trials[J].JAMA,2001,285:193-199.
  • 6Jadad A R,Moore R A,Carroll D,et al.Assessing the quality of reports of randomized clinical trials:is blinding necessary[J].Controlled clinical trials,1996,17(1):1-12.
  • 7张国柄,徐江海.替比夫定联合扶正化瘀胶囊治疗慢性乙型肝炎抗肝纤维化疗效分析[J].中国药物经济学,2012(6):170-171.
  • 8HERNANDEZ-GEA V,FRIEDMAN S L. Pathogenesis of liverfibrosis[J]. Annual review of pathology,2011(6) :425-456.
  • 9IWAISAKO K, BRENNER D A, KISSELEVA T. What,snew in liver fibrosis. The origin of myofibroblasts in liver fi-brosis[J]. Journal of gastroenterology and hepatology, 2012,27(S2): 65-68.
  • 10刘平,胡义杨,徐列明,李风华,顾宏图,刘成.扶正化瘀319方抗大鼠肝纤维化的研究[J].中国实验方剂学杂志,1997,3(4):20-24. 被引量:40

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部